GT Biopharma (NASDAQ:GTBP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does GT Biopharma (GTBP) operate in?

GT Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GT Biopharma Stock (NASDAQ: GTBP) stock price, news, charts, stock research, profile.

Open	$2.69
Close	-
Volume / Avg.	10.10K / 1.39M
Day Range	2.69 - 2.87
52 Wk Range	0.18 - 10.66
Market Cap	$5.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	2.04%
Days to Cover	1

Recent News

What's Going On With GT Biopharma Stock Tuesday?

GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered in a registered direct offering priced at-the-market under Nasdaq rules.

Dylan Berman

What's Going On With GT Biopharma Stock?

GT Biopharma shares are moving on heavy trading volume despite a lack of company-specific news. The stock is one of the top trending tickers on Stocktwits which may point to a rally led by retail traders. According to data from Benzinga Pro, more than 60.4 million shares have been traded in the session, far exceeding the stock's 100-day average of less than 11,000 shares.

Erica Kollmann

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About GT Biopharma Inc

Sector

Health Care

Industry

Biotechnology

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commer...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GT Biopharma (GTBP) stock?

You can purchase shares of GT Biopharma (NASDAQ:GTBP) through any online brokerage.

View our list of the best stock brokerages

Who are GT Biopharma (GTBP) competitors?

Other companies in GT Biopharma’s space includes: Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), NuCana (NASDAQ:NCNA), Portage Biotech (NASDAQ:PRTG) and Trevena (NASDAQ:TRVN).

What is the target price for GT Biopharma (GTBP) stock?

There is no analysis for GT Biopharma.

What is the forecast for GT Biopharma (GTBP) stock?

GT Biopharma has a consensus price target of $3.50.

Current stock price for GT Biopharma (GTBP)?

The stock price for GT Biopharma (NASDAQ: GTBP) is $2.7019 last updated Today at July 22, 2024 at 8:38 AM EDT.

Does GT Biopharma (GTBP) pay a dividend?

There are no upcoming dividends for GT Biopharma.

When is GT Biopharma (NASDAQ:GTBP) reporting earnings?

GT Biopharma’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is GT Biopharma (GTBP) going to split?

There is no upcoming split for GT Biopharma.

What sector and industry does GT Biopharma (GTBP) operate in?

GT Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

GT Biopharma

GT Biopharma (GTBP) Forecast